John M Wentworth — ASN Events
  1. Schedule
  2. John M Wentworth

John Wentworth

Walter and Eliza Hall Institute of Medical Research and Royal Melbourne Hospital, VIC, Australia

  • This delegate is presenting an abstract at this event.
  • Endocrinologist
John Wentworth is an adult endocrinologist based at Royal Melbourne Hospital and Walter and Eliza Hall Institute. His current research focusses on early diagnosis of type 1 diabetes and its prevention using immunotherapy. He established the Type1Screen family screening program in 2019 and in 2022 introduced in-home capillary blood autoantibody screening to ensure every Australian T1D family has access. He is working to offer testing to the broader population and continues to lead immunotherapy trials that aim to preserve beta cell function and prevent disease progression to insulin dependence.
Presentations this author is a contributor to:

IL-18 production from the NLRP1 inflammasome prevents obesity and metabolic syndrome (#366)

12:45 PM
Seth Masters
ADS Basic Symposium: Cytokines

GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of human insulin resistance (#238)

2:00 PM
John M Wentworth
ADS Basic Poster Discussions - Obesity and its implications

A combination of 15 SNPs and clinical features in relatives with islet autoantibodies improves prediction of Type 1 Diabetes: implications for prevention trials. (#43)

11:00 AM
John M Wentworth
ADS Clinical Orals: Type 1 Diabetes